Pharmaceutical Commerce - February 2023

Click the title above for a link to open the Pharmaceutical Commerce February 2023 issue in an interactive PDF format.

A multitude of conclusions surrounding distribution were reached at the Trade & Channels Strategies conference.

New Pharma Commerce column addresses the relevance of pricing.

As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

Post-pandemic conditions are improving for the temperature-controlled market, but, meanwhile, the technical demands are rising.

How cell and gene therapies can be safely protected as they move along the supply chain, even when temperature-related challenges present themselves.

A conversation with Nico Ros, co-founder and CTO of SkyCell.

Outlining those advances poised to drive increased use of integrated tactical planning (ITP) in helping manufacturers overcome persistent supply chain obstacles.

How artificial intelligence and real-world data has not just helped predict patient behavior, but has also been successful at the point-of-care for life sciences companies.  

Using technology to personalize customer engagement, build HCP trust.